Buyer Name: Cardiff and Vale University Health Board
Buyer Address: Woodland House, Maes-Y-Coed Road, Cardiff, UKL22, CF14 4HH, United Kingdom
Contact Name: nicola
Contact Email: nicola.williams33@wales.nhs.uk
Buyer Name: Cardiff and Vale University Health Board
Buyer Address: Woodland House, Maes-Y-Coed Road, Cardiff, UKL22, CF14 4HH, United Kingdom
Contact Name: nicola
Contact Email: nicola.williams33@wales.nhs.uk
Buyer Name: NHS Wales shared service partnership (hosted by Velindre)
Buyer Address: 4-5 Charnwood Court, Cardiff, UKL15, CF15 7QZ, United Kingdom
Contact Email: Corporate.Services2@wales.nhs.uk
This notice is to inform the public of a direct award for the provision of inherited cancer genetic testing services. The service is essential for the timely and accurate diagnosis of hereditary cancer syndromes, supporting clinical decision-making and patient care across NHS Wales. The contract has been awarded to a specialist provider with proven expertise and capability in delivering high-quality genetic testing aligned with national genomic standards. The award ensures continuity of service, compliance with clinical governance, and supports the strategic objectives of Genomics Partnership Wales.
No linked documents found for this notice.
Lot 1 Status: complete
Document Description: Not published
Award Title: Inherited Cancer Genetics
{
"awards": [
{
"aboveThreshold": true,
"contractPeriod": {
"endDate": "2026-12-31T23:59:59+00:00",
"startDate": "2026-01-01T00:00:00+00:00"
},
"documents": [
{
"datePublished": "2025-09-16T15:36:36+01:00",
"description": "Transparency notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "057031-2025",
"noticeType": "UK5",
"url": "https://www.find-tender.service.gov.uk/Notice/057031-2025"
}
],
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Medical analysis services",
"id": "85148000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKL22"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "services",
"milestones": [
{
"dueDate": "2025-10-06T23:59:59+01:00",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"relatedLots": [
"1"
],
"status": "pending",
"suppliers": [
{
"id": "GB-PPON-PZXY-1897-VDDJ",
"name": "Informed Genetics"
}
],
"title": "Inherited Cancer Genetics ",
"value": {
"amount": 450000.0,
"amountGross": 540000.0,
"currency": "GBP"
}
}
],
"buyer": {
"id": "GB-PPON-PPPR-7969-BTJG",
"name": "Cardiff and Vale University Health Board"
},
"date": "2025-09-16T15:36:36+01:00",
"id": "057031-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-059b82",
"parties": [
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Cardiff",
"postalCode": "CF14 4HH",
"region": "UKL22",
"streetAddress": "Woodland House, Maes-Y-Coed Road"
},
"contactPoint": {
"email": "nicola.williams33@wales.nhs.uk",
"name": "nicola"
},
"details": {
"classifications": [
{
"description": "Public authority - sub-central government",
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE"
},
{
"description": "Welsh devolved regulations apply",
"id": "GB-WLS",
"scheme": "UK_CA_DEVOLVED_REGULATIONS"
}
],
"url": "http://nwssp.nhs.wales/ourservices/procurement-services/"
},
"id": "GB-PPON-PPPR-7969-BTJG",
"identifier": {
"id": "PPPR-7969-BTJG",
"scheme": "GB-PPON"
},
"name": "Cardiff and Vale University Health Board ",
"roles": [
"buyer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Cardiff",
"postalCode": "CF15 7QZ",
"region": "UKL15",
"streetAddress": "4-5 Charnwood Court "
},
"contactPoint": {
"email": "Corporate.Services2@wales.nhs.uk"
},
"id": "GB-PPON-PXWV-6492-CGMN",
"identifier": {
"id": "PXWV-6492-CGMN",
"scheme": "GB-PPON"
},
"name": "NHS Wales shared service partnership (hosted by Velindre)",
"roleDetails": "Procurement Services is a core function of NHS Wales Shared Services Partnership (NWSSP), hosted by Velindre University NHS Trust. It delivers a comprehensive Procure-to-Pay (P2P) system across all NHS Wales Health Boards and Trusts. The service integrates local procurement teams with centralised sourcing, supply chain, and accounts payable functions to provide a unified, collaborative approach to",
"roles": [
"procuringEntity"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Birmingham",
"postalCode": "B32 1AF",
"region": "UKG31",
"streetAddress": "Unit 5, quinton business park, 11 Ridgeway, "
},
"contactPoint": {
"email": "Izzie.Coakley@nonacus.com"
},
"details": {
"scale": "large",
"vcse": false
},
"id": "GB-PPON-PZXY-1897-VDDJ",
"identifier": {
"id": "PZXY-1897-VDDJ",
"scheme": "GB-PPON"
},
"name": "Informed Genetics",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "This notice is to inform the public of a direct award for the provision of inherited cancer genetic testing services. The service is essential for the timely and accurate diagnosis of hereditary cancer syndromes, supporting clinical decision-making and patient care across NHS Wales. The contract has been awarded to a specialist provider with proven expertise and capability in delivering high-quality genetic testing aligned with national genomic standards. The award ensures continuity of service, compliance with clinical governance, and supports the strategic objectives of Genomics Partnership Wales.",
"documents": [
{
"description": "Not published",
"documentType": "conflictOfInterest",
"id": "conflictOfInterest"
}
],
"id": "CAV-DCO (25-26) 85",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "direct",
"procurementMethodDetails": "Direct award",
"procurementMethodRationale": "The decision to proceed with a direct award to the current supplier is based on the supplier\u2019s proven track record of delivering consistent, high-quality service and their deep understanding of our operational requirements. Maintaining continuity with the existing supplier ensures minimal disruption, preserves established workflows, and avoids the additional costs and risks associated with transitioning to a new provider. Furthermore, the supplier has demonstrated a strong commitment to partnership and continuous improvement, aligning well with our strategic objectives.",
"procurementMethodRationaleClassifications": [
{
"id": "singleSuppliersTechnicalReasons"
},
{
"id": "singleSuppliersUniqueWorkArtPerformance"
},
{
"id": "additionalRepeatExtensionPartialReplacement"
}
],
"riskDetails": "Changing suppliers at this stage presents several risks to contract performance, including potential service disruption, loss of operational continuity, and increased costs associated with onboarding a new provider. The current supplier has established familiarity with Cardiff and Vale university Health Board systems and processes, and replacing them could lead to delays, reduced efficiency, and quality issues during the transition period. Maintaining the existing relationship helps mitigate these risks and ensures consistent delivery aligned with organisational expectations.",
"status": "complete",
"title": "Inherited Cancer Genetic Testing"
}
}